{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:06:00Z","timestamp":1789088760834,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":98,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K01AA029706"],"award-info":[{"award-number":["K01AA029706"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS124819"],"award-info":[{"award-number":["1R01NS124819"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01411-x","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:54:39Z","timestamp":1780682079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroimaging evidence for a dopamine-independent association between motor cortex microstructure and Parkinson\u2019s disease severity"],"prefix":"10.1038","volume":"12","author":[{"given":"Praveen","family":"Honhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Tinaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Ebrahimian Sadabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannan","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansel T.","family":"Hillmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Zakiniaeiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Comley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd J.","family":"Finnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Scheinost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1411_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","volume":"6","author":"GE Alexander","year":"2004","unstructured":"Alexander, G. E. Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin. Neurosci. 6, 259\u2013280 (2004).","journal-title":"Dialogues Clin. Neurosci."},{"key":"1411_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00702-021-02452-7","volume":"129","author":"T Brucke","year":"2022","unstructured":"Brucke, T. & Brucke, C. Dopamine transporter (DAT) imaging in Parkinson\u2019s disease and related disorders. J. Neural Transm. (Vienna) 129, 581\u2013594 (2022).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1411_CR3","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","volume":"47","author":"S Morbelli","year":"2020","unstructured":"Morbelli, S. et al. EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur. J. Nucl. Med Mol. Imaging 47, 1885\u20131912 (2020).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"1411_CR4","first-page":"1879","volume":"39","author":"J Booij","year":"1998","unstructured":"Booij, J. et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson\u2019s disease. J. Nucl. Med 39, 1879\u20131884 (1998).","journal-title":"J. Nucl. Med"},{"key":"1411_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1755-5949.2007.00033.x","volume":"14","author":"P Emond","year":"2008","unstructured":"Emond, P., Guilloteau, D. & Chalon, S. PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter. CNS Neurosci. Ther. 14, 47\u201364 (2008).","journal-title":"CNS Neurosci. Ther."},{"key":"1411_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00974-7","volume":"13","author":"VS Kerstens","year":"2023","unstructured":"Kerstens, V. S. et al. [(18)F]FE-PE2I DAT correlates with Parkinson\u2019s disease duration, stage, and rigidity\/bradykinesia scores: a PET radioligand validation study. EJNMMI Res 13, 29 (2023).","journal-title":"EJNMMI Res"},{"key":"1411_CR7","doi-asserted-by":"publisher","first-page":"103347","DOI":"10.1016\/j.nicl.2023.103347","volume":"37","author":"VS Kerstens","year":"2023","unstructured":"Kerstens, V. S. et al. Longitudinal DAT changes measured with [(18)F]FE-PE2I PET in patients with Parkinson\u2019s disease; a validation study. Neuroimage Clin. 37, 103347 (2023).","journal-title":"Neuroimage Clin."},{"key":"1411_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0006-3495(94)80775-1","volume":"66","author":"PJ Basser","year":"1994","unstructured":"Basser, P. J., Mattiello, J. & LeBihan, D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 66, 259\u2013267 (1994).","journal-title":"Biophys. J."},{"key":"1411_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/jmrb.1996.0086","volume":"111","author":"PJ Basser","year":"1996","unstructured":"Basser, P. J. & Pierpaoli, C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson B 111, 209\u2013219 (1996).","journal-title":"J. Magn. Reson B"},{"key":"1411_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1148\/radiology.201.3.8939209","volume":"201","author":"C Pierpaoli","year":"1996","unstructured":"Pierpaoli, C., Jezzard, P., Basser, P. J., Barnett, A. & Di Chiro, G. Diffusion tensor MR imaging of the human brain. Radiology 201, 637\u2013648 (1996).","journal-title":"Radiology"},{"key":"1411_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.sult.2021.07.006","volume":"42","author":"E Martinez-Heras","year":"2021","unstructured":"Martinez-Heras, E., Grussu, F., Prados, F., Solana, E. & Llufriu, S. Diffusion-Weighted Imaging: Recent Advances and Applications. Semin Ultrasound CT MR 42, 490\u2013506 (2021).","journal-title":"Semin Ultrasound CT MR"},{"key":"1411_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","volume":"61","author":"H Zhang","year":"2012","unstructured":"Zhang, H., Schneider, T., Wheeler-Kingshott, C. A. & Alexander, D. C. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61, 1000\u20131016 (2012).","journal-title":"Neuroimage"},{"key":"1411_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1212\/WNL.0b013e318284070c","volume":"80","author":"CJ Cochrane","year":"2013","unstructured":"Cochrane, C. J. & Ebmeier, K. P. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 80, 857\u2013864 (2013).","journal-title":"Neurology"},{"key":"1411_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nicl.2017.07.011","volume":"16","author":"C Atkinson-Clement","year":"2017","unstructured":"Atkinson-Clement, C., Pinto, S., Eusebio, A. & Coulon, O. Diffusion tensor imaging in Parkinson\u2019s disease: Review and meta-analysis. Neuroimage Clin. 16, 98\u2013110 (2017).","journal-title":"Neuroimage Clin."},{"key":"1411_CR15","doi-asserted-by":"publisher","first-page":"531993","DOI":"10.3389\/fneur.2020.531993","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. & Burock, M. A. Diffusion Tensor Imaging in Parkinson\u2019s Disease and Parkinsonian Syndrome: A Systematic Review. Front Neurol. 11, 531993 (2020).","journal-title":"Front Neurol."},{"key":"1411_CR16","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/jnnp.2007.121525","volume":"78","author":"LL Chan","year":"2007","unstructured":"Chan, L. L. et al. Case control study of diffusion tensor imaging in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 78, 1383\u20131386 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1411_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mds.23917","volume":"27","author":"W Zhan","year":"2012","unstructured":"Zhan, W. et al. Regional alterations of brain microstructure in Parkinson\u2019s disease using diffusion tensor imaging. Mov. Disord. 27, 90\u201397 (2012).","journal-title":"Mov. Disord."},{"key":"1411_CR18","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3174\/ajnr.A2865","volume":"32","author":"NK Focke","year":"2011","unstructured":"Focke, N. K. et al. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. AJNR Am. J. Neuroradiol. 32, 2087\u20132092 (2011).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1411_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.neuroimage.2009.05.017","volume":"47","author":"RA Menke","year":"2009","unstructured":"Menke, R. A. et al. MRI characteristics of the substantia nigra in Parkinson\u2019s disease: a combined quantitative T1 and DTI study. Neuroimage 47, 435\u2013441 (2009).","journal-title":"Neuroimage"},{"key":"1411_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1148\/radiol.11102277","volume":"261","author":"JJ Wang","year":"2011","unstructured":"Wang, J. J. et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 261, 210\u2013217 (2011).","journal-title":"Radiology"},{"key":"1411_CR21","doi-asserted-by":"crossref","unstructured":"Beaulieu, C. The biological basis of diffusion anisotropy. Diffusion MRI: From Quantitative Measurement to In-vivo Neuroanatomy, Academic Press, 105\u2013126 (2009).","DOI":"10.1016\/B978-0-12-374709-9.00006-7"},{"key":"1411_CR22","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1002\/hbm.23628","volume":"38","author":"K Kamagata","year":"2017","unstructured":"Kamagata, K. et al. Gray Matter Abnormalities in Idiopathic Parkinson\u2019s Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging. Hum. Brain Mapp. 38, 3704\u20133722 (2017).","journal-title":"Hum. Brain Mapp."},{"key":"1411_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2018.02.046","volume":"51","author":"C Andica","year":"2018","unstructured":"Andica, C. et al. Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson\u2019s disease: Retrograde degeneration observed by tract-profile analysis. Parkinsonism Relat. Disord. 51, 55\u201360 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1411_CR24","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/jmri.27273","volume":"52","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Aberrant Fiber Coherence of Amygdala-Accumbens-Pallidum Pathway Is Associated With Disorganized Nigrostriatal-Nigropallidal Pathway in Parkinson\u2019s Disease. J. Magn. Reson Imaging 52, 1799\u20131808 (2020).","journal-title":"J. Magn. Reson Imaging"},{"key":"1411_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41531-021-00236-0","volume":"7","author":"T Ogawa","year":"2021","unstructured":"Ogawa, T. et al. White matter and nigral alterations in multiple system atrophy-parkinsonian type. NPJ Parkinsons Dis. 7, 96 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1411_CR26","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1002\/hbm.24760","volume":"40","author":"T Mitchell","year":"2019","unstructured":"Mitchell, T. et al. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism. Hum. Brain Mapp. 40, 5094\u20135107 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"1411_CR27","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1007\/s00330-015-4066-8","volume":"26","author":"K Kamagata","year":"2016","unstructured":"Kamagata, K. et al. Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease. Eur. Radio. 26, 2567\u20132577 (2016).","journal-title":"Eur. Radio."},{"key":"1411_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/syn.20670","volume":"63","author":"A Varrone","year":"2009","unstructured":"Varrone, A. et al. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse 63, 871\u2013880 (2009).","journal-title":"Synapse"},{"key":"1411_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1021\/jm960795d","volume":"40","author":"P Emond","year":"1997","unstructured":"Emond, P. et al. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4\u2019-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3\u2019,4\u2019-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med Chem. 40, 1366\u20131372 (1997).","journal-title":"J. Med Chem."},{"key":"1411_CR30","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1177\/0271678X20958755","volume":"41","author":"J Brumberg","year":"2021","unstructured":"Brumberg, J. et al. Simplified quantification of [(18)F]FE-PE2I PET in Parkinson\u2019s disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium. J. Cereb. Blood Flow. Metab. 41, 1291\u20131300 (2021).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1411_CR31","doi-asserted-by":"publisher","first-page":"fcae345","DOI":"10.1093\/braincomms\/fcae345","volume":"6","author":"P Honhar","year":"2024","unstructured":"Honhar, P. et al. Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [(18)F]FE-PE2I PET: independent validation with new insights. Brain Commun. 6, fcae345 (2024).","journal-title":"Brain Commun."},{"key":"1411_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1411_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins, G. T. et al. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: Comparison with the unified Parkinson\u2019s disease rating scale. Mov. Disord. 28, 668\u2013670 (2013).","journal-title":"Mov. Disord."},{"key":"1411_CR34","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori, E. et al. Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study. Mov. Disord. 32, 1457\u20131464 (2017).","journal-title":"Mov. Disord."},{"key":"1411_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.neurobiolaging.2014.10.029","volume":"36","author":"E Ofori","year":"2015","unstructured":"Ofori, E. et al. Increased free water in the substantia nigra of Parkinson\u2019s disease: a single-site and multi-site study. Neurobiol. Aging 36, 1097\u20131104 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1411_CR36","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/brain\/awv136","volume":"138","author":"E Ofori","year":"2015","unstructured":"Ofori, E. et al. Longitudinal changes in free-water within the substantia nigra of Parkinson\u2019s disease. Brain 138, 2322\u20132331 (2015).","journal-title":"Brain"},{"key":"1411_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/awv361","volume":"139","author":"PJ Planetta","year":"2016","unstructured":"Planetta, P. J. et al. Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism. Brain 139, 495\u2013508 (2016).","journal-title":"Brain"},{"key":"1411_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.parkreldis.2019.05.033","volume":"65","author":"G Arribarat","year":"2019","unstructured":"Arribarat, G. et al. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson\u2019s disease. Parkinsonism Relat. Disord. 65, 146\u2013152 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1411_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2019.01.007","volume":"62","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. Multimodal dopaminergic and free-water imaging in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 62, 10\u201315 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1411_CR40","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/awx146","volume":"140","author":"RG Burciu","year":"2017","unstructured":"Burciu, R. G. et al. Progression marker of Parkinson\u2019s disease: a 4-year multi-site imaging study. Brain 140, 2183\u20132192 (2017).","journal-title":"Brain"},{"key":"1411_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/mdc3.13687","volume":"10","author":"N Heng","year":"2023","unstructured":"Heng, N. et al. Striatal Dopamine Loss in Early Parkinson\u2019s Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging. Mov. Disord. Clin. Pr. 10, 539\u2013546 (2023).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1411_CR42","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/mds.26251","volume":"30","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson\u2019s disease. Mov. Disord. 30, 1229\u20131236 (2015).","journal-title":"Mov. Disord."},{"key":"1411_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep35601","volume":"6","author":"MC Wen","year":"2016","unstructured":"Wen, M. C. et al. White matter microstructural characteristics in newly diagnosed Parkinson\u2019s disease: An unbiased whole-brain study. Sci. Rep. 6, 35601 (2016).","journal-title":"Sci. Rep."},{"key":"1411_CR44","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s00415-013-7080-2","volume":"260","author":"N Lenfeldt","year":"2013","unstructured":"Lenfeldt, N. et al. Diffusion tensor imaging and correlations to Parkinson rating scales. J. Neurol. 260, 2823\u20132830 (2013).","journal-title":"J. Neurol."},{"key":"1411_CR45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrn4038","volume":"16","author":"M Jahanshahi","year":"2015","unstructured":"Jahanshahi, M., Obeso, I., Rothwell, J. C. & Obeso, J. A. A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition. Nat. Rev. Neurosci. 16, 719\u2013732 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"1411_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnana.2020.00013","volume":"14","author":"A Emmi","year":"2020","unstructured":"Emmi, A., Antonini, A., Macchi, V., Porzionato, A. & De Caro, R. Anatomy and Connectivity of the Subthalamic Nucleus in Humans and Non-human Primates. Front Neuroanat. 14, 13 (2020).","journal-title":"Front Neuroanat."},{"key":"1411_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58825-z","volume":"16","author":"TS Binns","year":"2025","unstructured":"Binns, T. S. et al. Shared pathway-specific network mechanisms of dopamine and deep brain stimulation for the treatment of Parkinson\u2019s disease. Nat. Commun. 16, 3587 (2025).","journal-title":"Nat. Commun."},{"key":"1411_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuron.2020.02.012","volume":"106","author":"W Chen","year":"2020","unstructured":"Chen, W. et al. Prefrontal-Subthalamic Hyperdirect Pathway Modulates Movement Inhibition in Humans. Neuron 106, 579\u2013588 e573 (2020).","journal-title":"Neuron"},{"key":"1411_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25366-0","volume":"12","author":"A Oswal","year":"2021","unstructured":"Oswal, A. et al. Neural signatures of hyperdirect pathway activity in Parkinson\u2019s disease. Nat. Commun. 12, 5185 (2021).","journal-title":"Nat. Commun."},{"key":"1411_CR50","doi-asserted-by":"publisher","unstructured":"Chu, H. Y. et al. Dysfunction of motor cortices in Parkinson\u2019s disease. Cereb Cortex 34 https:\/\/doi.org\/10.1093\/cercor\/bhae294 (2024).","DOI":"10.1093\/cercor\/bhae294"},{"key":"1411_CR51","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1002\/mds.26325","volume":"30","author":"N Schuff","year":"2015","unstructured":"Schuff, N. et al. Diffusion imaging of nigral alterations in early Parkinson\u2019s disease with dopaminergic deficits. Mov. Disord. 30, 1885\u20131892 (2015).","journal-title":"Mov. Disord."},{"key":"1411_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JPD-161011","volume":"7","author":"N Lenfeldt","year":"2017","unstructured":"Lenfeldt, N., Eriksson, J., Astrom, B., Forsgren, L. & Mo, S. J. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson\u2019s Disease: Challenging Results. J. Parkinsons Dis. 7, 129\u2013142 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"1411_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep38070","volume":"6","author":"SJ Son","year":"2016","unstructured":"Son, S. J., Kim, M. & Park, H. Imaging analysis of Parkinson\u2019s disease patients using SPECT and tractography. Sci. Rep. 6, 38070 (2016).","journal-title":"Sci. Rep."},{"key":"1411_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnagi.2019.00057","volume":"11","author":"S Lorio","year":"2019","unstructured":"Lorio, S., Sambataro, F., Bertolino, A., Draganski, B. & Dukart, J. The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson\u2019s Disease. Front Aging Neurosci. 11, 57 (2019).","journal-title":"Front Aging Neurosci."},{"key":"1411_CR55","doi-asserted-by":"publisher","first-page":"e0175674","DOI":"10.1371\/journal.pone.0175674","volume":"12","author":"C Caspell-Garcia","year":"2017","unstructured":"Caspell-Garcia, C. et al. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. PLoS One 12, e0175674 (2017).","journal-title":"PLoS One"},{"key":"1411_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jocn.2018.01.023","volume":"50","author":"F Knossalla","year":"2018","unstructured":"Knossalla, F. et al. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson\u2019s disease. J. Clin. Neurosci. 50, 199\u2013202 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"1411_CR57","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1002\/hbm.23697","volume":"38","author":"G Barbagallo","year":"2017","unstructured":"Barbagallo, G. et al. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson\u2019s disease. Hum. Brain Mapp. 38, 4716\u20134729 (2017).","journal-title":"Hum. Brain Mapp."},{"key":"1411_CR58","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1411_CR59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"1411_CR60","doi-asserted-by":"publisher","first-page":"102503","DOI":"10.1118\/1.4819820","volume":"40","author":"X Jin","year":"2013","unstructured":"Jin, X., Mulnix, T., Gallezot, J. D. & Carson, R. E. Evaluation of motion correction methods in human brain PET imaging-a simulation study based on human motion data. Med Phys. 40, 102503 (2013).","journal-title":"Med Phys."},{"key":"1411_CR61","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S1053-8119(03)00336-7","volume":"20","author":"JL Andersson","year":"2003","unstructured":"Andersson, J. L., Skare, S. & Ashburner, J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage 20, 870\u2013888 (2003).","journal-title":"Neuroimage"},{"key":"1411_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1118\/1.598130","volume":"24","author":"C Studholme","year":"1997","unstructured":"Studholme, C., Hill, D. L. & Hawkes, D. J. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys. 24, 25\u201335 (1997).","journal-title":"Med Phys."},{"key":"1411_CR63","first-page":"209","volume":"2006","author":"X Papademetris","year":"2006","unstructured":"Papademetris, X. et al. BioImage Suite: An integrated medical image analysis suite: An update. Insight J. 2006, 209 (2006).","journal-title":"Insight J."},{"key":"1411_CR64","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1109\/42.896788","volume":"19","author":"C Studholme","year":"2000","unstructured":"Studholme, C., Constable, R. T. & Duncan, J. S. Accurate alignment of functional EPI data to anatomical MRI using a physics-based distortion model. IEEE Trans. Med Imaging 19, 1115\u20131127 (2000).","journal-title":"IEEE Trans. Med Imaging"},{"key":"1411_CR65","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","volume":"125","author":"JLR Andersson","year":"2016","unstructured":"Andersson, J. L. R. & Sotiropoulos, S. N. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 125, 1063\u20131078 (2016).","journal-title":"Neuroimage"},{"key":"1411_CR66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroimage.2014.10.026","volume":"105","author":"A Daducci","year":"2015","unstructured":"Daducci, A. et al. Accelerated Microstructure Imaging via Convex Optimization (AMICO) from diffusion MRI data. Neuroimage 105, 32\u201344 (2015).","journal-title":"Neuroimage"},{"key":"1411_CR67","doi-asserted-by":"publisher","first-page":"e0217118","DOI":"10.1371\/journal.pone.0217118","volume":"14","author":"JM Guerrero","year":"2019","unstructured":"Guerrero, J. M. et al. Optimizing the intrinsic parallel diffusivity in NODDI: An extensive empirical evaluation. PLoS One 14, e0217118 (2019).","journal-title":"PLoS One"},{"key":"1411_CR68","doi-asserted-by":"publisher","first-page":"118749","DOI":"10.1016\/j.neuroimage.2021.118749","volume":"245","author":"CS Parker","year":"2021","unstructured":"Parker, C. S. et al. Not all voxels are created equal: Reducing estimation bias in regional NODDI metrics using tissue-weighted means. Neuroimage 245, 118749 (2021).","journal-title":"Neuroimage"},{"key":"1411_CR69","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","volume":"12","author":"HW Muller-Gartner","year":"1992","unstructured":"Muller-Gartner, H. W. et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow. Metab. 12, 571\u2013583 (1992).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1411_CR70","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/01.WCB.0000033967.83623.34","volume":"22","author":"Y Wu","year":"2002","unstructured":"Wu, Y. & Carson, R. E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow. Metab. 22, 1440\u20131452 (2002).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1411_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273\u2013289 (2002).","journal-title":"Neuroimage"},{"key":"1411_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2015.06.039","volume":"154","author":"D Matuskey","year":"2015","unstructured":"Matuskey, D. et al. A preliminary study of dopamine D2\/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO. Drug Alcohol Depend. 154, 167\u2013173 (2015).","journal-title":"Drug Alcohol Depend."},{"key":"1411_CR73","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2967\/jnumed.113.132928","volume":"55","author":"JD Gallezot","year":"2014","unstructured":"Gallezot, J. D. et al. Parametric Imaging and Test-Retest Variability of (1)(1)C-(+)-PHNO Binding to D(2)\/D(3) Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner. J. Nucl. Med 55, 960\u2013966 (2014).","journal-title":"J. Nucl. Med"},{"key":"1411_CR74","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/jcbfm.2013.134","volume":"33","author":"M Naganawa","year":"2013","unstructured":"Naganawa, M. et al. Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter. J. Cereb. Blood Flow. Metab. 33, 1886\u20131896 (2013).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1411_CR75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/syn.20696","volume":"64","author":"YS Ding","year":"2010","unstructured":"Ding, Y. S. et al. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT. Synapse 64, 30\u201338 (2010).","journal-title":"Synapse"},{"key":"1411_CR76","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neuroimage.2007.12.035","volume":"40","author":"S Mori","year":"2008","unstructured":"Mori, S. et al. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 40, 570\u2013582 (2008).","journal-title":"Neuroimage"},{"key":"1411_CR77","doi-asserted-by":"publisher","first-page":"840328","DOI":"10.3389\/fpain.2022.840328","volume":"3","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. & Furst, A. J. Brainstem Diffusion Tensor Tractography and Clinical Applications in Pain. Front Pain. Res (Lausanne) 3, 840328 (2022).","journal-title":"Front Pain. Res (Lausanne)"},{"key":"1411_CR78","doi-asserted-by":"publisher","first-page":"e0213952","DOI":"10.1371\/journal.pone.0213952","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Diffusion tensor tractography of brainstem fibers and its application in pain. PLoS One 15, e0213952 (2020).","journal-title":"PLoS One"},{"key":"1411_CR79","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1523\/JNEUROSCI.3241-12.2013","volume":"33","author":"MC Keuken","year":"2013","unstructured":"Keuken, M. C. et al. Ultra-high 7T MRI of structural age-related changes of the subthalamic nucleus. J. Neurosci. 33, 4896\u20134900 (2013).","journal-title":"J. Neurosci."},{"key":"1411_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.25682","volume":"87","author":"D Matuskey","year":"2020","unstructured":"Matuskey, D. et al. Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging. Ann. Neurol. 87, 329\u2013338 (2020).","journal-title":"Ann. Neurol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01411-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:06:42Z","timestamp":1789085202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01411-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01411-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Xiaomeng Zhang, Bradley A. Hooker, Sjoerd J. Finnema and Robert A. Comley are full-time employees of Abbvie, Inc. However, their employment does not constitute a competing interest to the findings reported in this study. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"216"}}